Andy Dray,
Chief Scientist, AstraZeneca R & D Montreal. 

Trained in pharmacology (University of St Andrews, Scotland ) and Neuropharmacology at the University of Birmingham, UK (PhD 1971).

Post doc in Pharmacology at School of Pharmacy, University of London and in the Dept Physiology, Duke University, USA.

Became Head of Laboratory of Neuropharmacology, MRC Neuropharmacology Research Unit, Cambridge UK.

Appointed Assistant Professor and later Associate Professor of Pharmacology at University of Arizona, USA.

In 1985 Joined Sandoz as Head of Pharmacology at the Sandoz Insititute for Medical Research, London, UK

1995. Moved to Astra Pain Control, Montreal, Canada in becoming Director of Pharmacology at AstraZeneca Research and Development, Montreal.

In 2002 appointed Chief Scientist for AstraZeneca, at AstraZeneca Research and Development, Montreal.

Interests